What Drove A Nearly 2x Rise In Boston Scientific's Profits?
This can primarily be attributed to an expansion of its operating margin and lower taxes.
Stay updated with breaking news from Apollo Endosurgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This can primarily be attributed to an expansion of its operating margin and lower taxes.
/PRNewswire/ -- Enteral Feeding Devices Market in terms of revenue was estimated to be worth $4.0 billion in 2024 and is poised to reach $5.6 billion by 2029,...
Operator: Good morning, and welcome to the Boston Scientific First Quarter 2024 Earnings Call. All participants will be in listen-only mode.
The company reported revenue of $3.7 billion and adjusted earnings of $0.55 per share, compared to the consensus estimates of $3.6 billion and $0.51, respectively.
A Strategic SWOT Insight into Boston Scientific's Market Position and Future Prospects